drug
aclidinium bromide
Marketedupdated 3mo agoby Covis Group Sarl
Approvedcommunity read0 votes
indications
investigational
COPD
all catalysts(0)
nothing on the calendar yet
Trials studying aclidinium bromide
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 13, 2029
~2.6 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Mar 13, 2029formulationUS 100859742.6y
- Mar 13, 2029formulationUS 110005172.6y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that